-
Novel URAT1 Inhibitor Successful in Proof-of-Concept Trial & More Late-Breaking Abstracts
Robert Keenan, MD, MPH, MBA, presented one of five late-breaking abstracts on the final day of ACR Convergence 2023. He discussed research showing the efficacy of AR882 in gout compared to allopurinol. Other cutting-edge science in the session related to immunosuppressant use in long-term IgG4-RD, TLR7/8 inhibition in cutaneous lupus erythematosus, long-acting steroid injections for…
More news from #ACR23
-
Read more: Rare Inborn Errors of Immunity Can Inform More Common Autoimmune Diseases
Rare Inborn Errors of Immunity Can Inform More Common Autoimmune Diseases
Experts in the field including Daniel Kastner, MD, PhD, discussed their work on extrapolating insights on the mechanisms of specific inborn errors of immunity to more common rheumatologic diseases. Dr. Kastner gave an overview of the landscape of inborn errors of immunity, highlighting immunodeficiencies, autoimmunity, and autoinflammatory diseases.
-
Read more: Dermatologist Shares Efficacy of Monoclonal Antibody for Treatment of Lupus Rashes
Dermatologist Shares Efficacy of Monoclonal Antibody for Treatment of Lupus Rashes
Anifrolumab gained U.S. Food and Drug Administration approval for use in systemic lupus in 2021, and the drug has had positive results among adults and adolescents with recalcitrant cutaneous lupus erythematosus, too. Katharina S. Shaw, MD, reviewed commonly observed rashes in rheumatologic patients and how to treat them.
-
Read more: Healthcare Providers Discuss Compassion for Self and Others — How to Practice It and How to Teach It
Healthcare Providers Discuss Compassion for Self and Others — How to Practice It and How to Teach It
Self-compassion is a way to protect against burnout for healthcare professionals. Vaneet Sandhu, MD, MS, RhMSUS, explained how compassion fatigue and fear of compassion are related, and how to incorporate compassion curriculum into healthcare training.
-
Read more: Panelists Discuss How and When to Safely Use Steroids in RA
Panelists Discuss How and When to Safely Use Steroids in RA
Rheumatologists may be tempted to use steroids in patients with very active disease as they wait for a disease-modifying antirheumatic drug to take effect. But Vivian Bykerk, MD, cautioned in a Meet the Panel session that this strategy can be counterproductive.
-
Read more: Experts Review Nervous System Manifestations in Sjögren’s Syndrome
Experts Review Nervous System Manifestations in Sjögren’s Syndrome
Brent P. Goodman, MD, Arun D. Varadhachary, MD, PhD, and Julius Birnbaum, MD, discussed the challenging complications of the nervous system that can present in patients with Sjögren’s syndrome, as well as practical strategies for the management of them.